Neoplasm Metastasis Clinical Trials

A listing of Neoplasm Metastasis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 24 clinical trials
Treatment for Mixed Urinary Incontinence: Mid-urethral Sling vs. Botox A

The primary outcome for this trial is the change in severity of MUI symptoms which will be measured at 6 months using the Urogenital Distress Inventory. Secondary objectives include identifying predictors of treatment failure and cost-effectiveness of treatments. Safety and adverse events data will also be collected.

  • 0 views
  • 19 Feb, 2024
  • 1 location
The influence of nicotinic hepatic metabolism on neuroreceptor substrates of nicotine addiction

., the severity of nicotine dependence), such that NMR is the strongest genetically-informed biomarker of smoking cessation. Differences in brain receptor levels secondary to differing durations of nicotine present in the brains of slow versus fast nicotine metabolizers is hypothesized to account for the effects of the NMR on quitting …

  • 0 views
  • 19 Feb, 2024
  • 1 location
CEA for the delineation of primary and recurrent tumor and metastases in patients undergoing curative surgery for colorectal cancer

SGM-101 is a fluorochrome-labeled anti-carcino-embryonic antigen (CEA) monoclonal antibody. What this means is that part of SGM-101 is a chemical that is attracted to and will attach to the cells of your cancer. Another part of SGM-101 is a chemical that will glow when infrared light is shined on it. …

  • 0 views
  • 19 Feb, 2024
  • 1 location
METAMORPH

This is a cohort study of women with suspected or confirmed recurrent breast cancer, with accessible tumor by standard clinical biopsy, prior to starting a new therapy for recurrent metastatic disease. Study participants will be ascertained from the population of all persons greater than eighteen years of age receiving care …

  • 0 views
  • 19 Feb, 2024
  • 1 location
DEVELOPING ORAL LT3 THERAPY FOR HEART FAILURE (DOT3HF)

Parallel, Randomized, Double-Blind, Placebo-Controlled Crossover Clinical Trial The primary objective is to evaluate the safety of oral LT3 in heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) The secondary objective is to evaluate the feasibility and preliminary efficacy outcomes of oral LT3 therapy …

  • 0 views
  • 19 Feb, 2024
  • 1 location
FES PET/CT in Endocrine Refractory Breast Cancer

  Positron emission tomography (PET/CT) imaging will be used to evaluate estrogen receptor (ER) activity, in sites of metastatic disease, using the investigational radiotracer [18F]fluoroestradiol (FES).  Imaging will occur prior to starting new therapy.

  • 0 views
  • 19 Feb, 2024
  • 2 locations
A phase IV prospective randomized open-label single-center study of pulse wave velocity evaluation tacrolimus time in therapeutic range and co-efficient of tacrolimus variation of African American kidney transplant recipients receiving immediate release tacrolimus capsules (IR-Tac) or extended release tacrolimus tablets (LCPT)

Pulse wave velocity and vascular compliance measurements are two non-invasive tests that are used to evaluate how well patients blood vessels adapt to each heartbeat. The secondary purpose is to look at the effectiveness and safety of extended release tacrolimus tablets administered once-daily compared to generic tacrolimus capsules administered twice-daily …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

Additional samples will be collected (whole blood RNA, DNA) for potential secondary studies.

  • 0 views
  • 19 Feb, 2024
  • 1 location
(PREDICT) A Multi-Center Study in Patients Undergoing Anthracycline-Based Chemotherapy to Assess the Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment

Biomarkers are chemical markers found in the blood and can be released in response to cardiac injury. Additional secondary objectives are to define the sensitivity and specificity of echocardiography for the detection of cardiotoxicity and determine the natural history of anthracycline cardiotoxicity in patients identified as high risk via biomarkers.

  • 0 views
  • 19 Feb, 2024
  • 1 location
The Association Between CBT-I Dose and Innate Immunity in Insomnia and Fatigue in Prostate Cancer Patients

The research study is being conducted secondary and after your completion of the primary study (Effect of Radiation Therapy on Sleepiness and Activity in Prostate and Breast Cancer Patients).

  • 0 views
  • 19 Feb, 2024
  • 1 location